Objective-To determine the variation in management of genital herpes by genitourinary physicians, and whether their duration of experience or gender influence their clinical management. Methods-A postal questionnaire was sent to UK consultant genitourinary physicians with detailed questions about management of primary and recurrent herpes. The gender and duration of genitourinary medicine experience of the physicians were also recorded. Results-One hundred and eighty two questionnaires were sent, 112 (62%) returned. Eighty-one (72%) physicians treat all patients with primary genital herpes, but physicians with more than 20 years experience were significantly (p < 0.05) more likely to treat only "severe"y primary attacks. Most experienced physicians were also most likely (p < 0.05) to prescribe topical acyclovir. Prescription of suppressive acyclovir was also influenced by the experience of the physician, the least experienced physicians being more likely to prescribe to patients who were HIV antibody positive or to those entering new relationships, whereas the more experienced prescribed to those patients who were particularly anxious (p < 0.05 for each of these). Male physicians were significantly more likely to agree with the proposition that men cope better with genital herpes (54%) than female physicians (24%, p < 0-01).
physician, the least experienced physicians being more likely to prescribe to patients who were HIV antibody positive or to those entering new relationships, whereas the more experienced prescribed to those patients who were particularly anxious (p < 0.05 for each of these). Male physicians were significantly more likely to agree with the proposition that men cope better with genital herpes (54%) than female physicians (24%, p < 0-01). Apart from the annual attack rate, physi- The finding that the most experienced physicians are more likely to reserve oral acyclovir for severe attacks may have several possible explanations. It may be that these physicians have developed counselling skills which enable them to support the patients through mild attacks without recourse to medication. Topical acyclovir is more popular with this group of physicians and this is possibly being used in place of oral therapy for less severe attacks. Furthermore, as acyclovir cream was launched before the oral prepara- Cost may be an important factor in the decision to prescribe suppressive therapy.' We found financial restraints to be uncommon at present, but an increase in departmental fundholding may change this. Some practioners indicated on our questionnaire that the patients who are on suppressive therapy are asked to request repeat prescriptions from their general practioner after the initiation of suppressive therapy in the genitourinary clinic, this has implications for patient care and in particular confidentiality.
There are a number of studies showing differences between men and women in regard to illness and behaviour.'0 It may be that illness is less socially acceptable in men, and men may minimise their symptoms or distress compared with women. On the other hand, doctors may identify with patients of the same sex as themselves, and attribute greater ability to cope as a result to those more like themselves. Physicians gender might therefore have an indirect influence on prescribing habits, although we did not assess this in the questionnaire.
This survey has documented a range of -different management strategies for genital herpes by consultant genitourinary physicians. This is not surprising considering the variation amongst physicians in the management of other sexually transmitted diseases such as chlamydial cervicitis,"1 where many physicians use different treatment and have different follow-up policies for test of cure. Our study not only shows such differences but also delineates the effect that the experience and gender of the physician has upon them. Further work on the doctor/patient interaction in genital herpes and other genitourinary conditions to explore this relationship is warranted.
